Pennsylvania sues 19 companies over alleged insulin pricing
The state alleges manufacturers and pharmacy-benefit managers used pricing and drug-formulary practices that raised costs. The claims have not been decided by a court.
The state alleges manufacturers and pharmacy-benefit managers used pricing and drug-formulary practices that raised costs. The claims have not been decided by a court.